Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$22,590
-0.4%
Shares
Shares Volume: 753 Shares
Average Share Price: $30
INSIDER
Heyman Richard A.
(Director)
reported on Oct 22 2024
traded on Oct 18 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 188,245 |
| PURCHASES/SALES 1Y | 0 / 21 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $31,433.54 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 6 |
| PURCHASES/SALES 1Y | 0 / 96 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $864,208.18 |
| COMPANY PREVIOUS TRADES |